Search research articles
Contact Us
Filters
Showing results (471-480 of 494) with videos related to
Page
of 50
Sort By:
Journal of Medicinal Chemistry
|
November 1, 2024
Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer
Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu, et al.
Journal of Medicinal Chemistry
|
July 19, 2018
Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression
Chong Qin, Yang Hu, Bing Zhou, et al.
Conservation Biology : the Journal of the Society for Conservation Biology
|
April 10, 2013
Ability of matrix models to explain the past and predict the future of plant populations
Elizabeth E Crone, Martha M Ellis, William F Morris, et al.
Journal of Medicinal Chemistry
|
April 8, 2025
Correction to "Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer"
Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu, et al.
Blood
|
December 24, 2013
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia
Erika K Keeton, Kristen McEachern, Keith S Dillman, et al.
Cancer Cell
|
December 8, 2009
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors
Michael Hedvat, Dennis Huszar, Andreas Herrmann, et al.
Journal of Medicinal Chemistry
|
September 6, 2019
Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies
Harold G Selnick, J Fred Hess, Cuyue Tang, et al.
Journal of Medicinal Chemistry
|
November 25, 2024
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα)
Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, et al.
Molecular Cancer Therapeutics
|
December 18, 2013
Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signaling
Neil R Michaud, Youzhen Wang, Kristen A McEachern, et al.
Nature
|
May 14, 2025
STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity
Jiajia Zhou, Kole Tison, Haibin Zhou, et al.
Page
of 50
Search research articles
Search
Showing results (471-480 of 494) with videos related to
Sort By:
Page
of 50
Journal of Medicinal Chemistry
|
November 1, 2024
Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer
Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu, et al.
Journal of Medicinal Chemistry
|
July 19, 2018
Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression
Chong Qin, Yang Hu, Bing Zhou, et al.
Conservation Biology : the Journal of the Society for Conservation Biology
|
April 10, 2013
Ability of matrix models to explain the past and predict the future of plant populations
Elizabeth E Crone, Martha M Ellis, William F Morris, et al.
Journal of Medicinal Chemistry
|
April 8, 2025
Correction to "Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer"
Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu, et al.
Blood
|
December 24, 2013
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia
Erika K Keeton, Kristen McEachern, Keith S Dillman, et al.
Cancer Cell
|
December 8, 2009
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors
Michael Hedvat, Dennis Huszar, Andreas Herrmann, et al.
Journal of Medicinal Chemistry
|
September 6, 2019
Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies
Harold G Selnick, J Fred Hess, Cuyue Tang, et al.
Journal of Medicinal Chemistry
|
November 25, 2024
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα)
Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, et al.
Molecular Cancer Therapeutics
|
December 18, 2013
Novel neutralizing hedgehog antibody MEDI-5304 exhibits antitumor activity by inhibiting paracrine hedgehog signaling
Neil R Michaud, Youzhen Wang, Kristen A McEachern, et al.
Nature
|
May 14, 2025
STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity
Jiajia Zhou, Kole Tison, Haibin Zhou, et al.
Page
of 50